How badly managed
a pharma company can be
when stock is selling at market cap with a multiple of 1 to its revenue.
Also has cash in its kitty.
Just unbelievable.
Mayne management is diggin in about the take over bid price negotiation if one can call it
that ,does it also mean IF THE MANAGEMENT IS AWARE OF
A GOOD jUNE QRTR AS THEY HAV SAID THEY WILL MEET THEIR ANNUAL GUIDANCE.
If they meet their annual guidance then COSETTE CASE on short term basis falls apart and MAYNE view is supported in a way.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.03 |
Change
-0.170(3.27%) |
Mkt cap ! $408.6M | |||
| Open | High | Low | Value | Volume |
| $5.20 | $5.21 | $5.03 | $2.804M | 555.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14654 | $5.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.14 | 3111 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |